Premium accounts now available! Sign up and create a premium account. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Image

[Articles] Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial

Journal content Created on 25 Aug 2026 The Lancet Oncology

Zhengbo Song, Liming Zhu, Ying Liu, Rongbo Lin, Xingya Li, Yongzhong Luo, Yuan Yuan, Huaqiu Shi, Yiping Zhang, Baoyuan Zhang, Yinxin Zhu, Zaiqi Wang, Xiangdong Cheng

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 57
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement